Teropavimab | Interleukin Related interleukin-related.com

Product Name :
Teropavimab

Search keywords :
Teropavimab

drugId :
null

Target Vo:
HIV envelope protein gp120

Target Vo Short Name :
gp120

Moa_Name:
HIV envelope protein gp120 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
The Rockefeller University

Active Company_Name :
Fountain (Beijing) Pharmaceutical Technology Development Co Ltd

Active Indication_Name:
HIV Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glucose Transporter GLUT4 Antibody (YA753)
PDGFR alpha Antibody
CDC37 Antibody: CDC37 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 44 kDa, targeting to Hsp90 co-chaperone Cdc37 (CDC37). It can be used for WB,IHC-P,IP,FC assays in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts